Upstream Bio posts VIBRANT Phase 2 results for verekitug in nasal polypsSep 18Trial updateUpstream Bio Inc.verekitug
Upstream Bio sets Phase 3 plans for verekitug in asthma and CRSwNPSep 1Clinical readoutUpstream Bio Inc.verekitug
Upstream Bio reports Q2 2026 results, COPD enrollment complete, Phase 3 on track for Q1 2027Aug 11Quarterly updateUpstream Bio Inc.verekitug
Sign inSign in